NCT04550767

Brief Summary

Bacterial infections in people who inject psychoactive substances

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 17, 2012

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 3, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
Last Updated

September 18, 2020

Status Verified

September 1, 2020

Enrollment Period

6.9 years

First QC Date

September 3, 2020

Last Update Submit

September 16, 2020

Conditions

Bacterial Infection

Keywords

Psychoactive substanceIntravenous substance abuseInjection drug userRisk reductionPsychoactive substances

Outcome Measures

Primary Outcomes (3)

  • Types of bacterial infections

    Types of bacterial infections : local or systemic:

    1 day

  • Psychoactive substances involved in each type of bacterial infections

    Psychoactive substances involved in each type of bacterial infections

    1 day

  • Types of injections in each type of infections

    Types of injections in each type of infections

    1 day

Study Arms (2)

local infections

local infections

systemic infections

systemic infections

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes all injection drug users, hospitalized at Montpellier University Hospital for bacterial infection related to the injection of one or several psychoactive substance(s).

You may qualify if:

  • Bacterial infection occurring in injection drug users and linked to injection
  • Hospitalized at Montpellier University Hospital

You may not qualify if:

  • No injection
  • No use of a psychoactive substance
  • Viral or fungal infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34290, France

Location

MeSH Terms

Conditions

Bacterial InfectionsSubstance Abuse, IntravenousRisk Reduction Behavior

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfectionsSubstance-Related DisordersChemically-Induced DisordersMental DisordersBehavior

Study Officials

  • Hélène Peyrière, PH

    UH Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2020

First Posted

September 16, 2020

Study Start

January 17, 2012

Primary Completion

December 1, 2018

Study Completion

January 1, 2019

Last Updated

September 18, 2020

Record last verified: 2020-09

Locations

FR(1)